MedTrace Logo

Cape Town Young Women's Health CoOp

NCT02974998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-01-08

No results posted yet for this study

Summary

This two-arm cluster randomized trial tested a gender-focused comprehensive HIV testing and counselling (HTC) program, the Young Women's Health CoOp (YWHC) with a standard HTC program and targeted female adolescents (aged 16-19) who use substances and have dropped out of school. To evaluate the process, the study examined the feasibility of using peer role models as recruiters and co-facilitators of the intervention and monitored fidelity to the intervention. Efficacy of the intervention on behavioral and biological outcomes, and on linkages to health services, through follow-up visits conducted 6- and 12-months post-enrollment was also assessed.

Conditions

  • Condomless Sex
  • Human Immunodeficiency Virus (HIV)
  • Sexually Transmitted Infections (STIs)
  • Alcohol and Drug Use
  • Violence and Victimization
  • Access and Linkage to Healthcare
  • Education Advancement

Interventions

BEHAVIORAL

Young Women's Health CoOp (YWHC)

Participants received HTC and engaged in a two-session gender-focused intervention. The intervention included information addressing the intersection of substance use, sexual risk, and violence through skill building, role-play, and rehearsal. The intervention also encouraged positive goal-seeking to access linkages to health care within the larger social ecological framework of where the young women live.

BEHAVIORAL

Standard HTC

Participants received the standard HTC available in South Africa for this population.

Sponsors & Collaborators

  • Medical Research Council, South Africa

    collaborator OTHER

  • RTI International

    lead OTHER

Principal Investigators

  • Felicia Browne, ScD · RTI International

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-11-26
Completion
2019-11-26

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02974998 on ClinicalTrials.gov